Faisal M Sanai (F M Sanai, Faisal Sanai)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Hepatitis B Virus

Top Venues

Journal of viral hepatitis

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Wesam Bahitham, Siraj Alghamdi, Ibrahim Omer, Ali Alsudais, Ilana Hakeem, Arwa Alghamdi, Reema Abualnaja, Faisal M Sanai, Alexandre Soares Rosado, Consolato Maria Sergi
Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Biomedicines 12 (3) (2024)
Saleh A Alqahtani, Yusuf Yilmaz, Mohamed El Kassas, Khalid Alswat, Faisal M Sanai, May AlZahrani, Faisal Abaalkhail, Manal AlShaikh, Waleed K Al-Hamoudi, Fatema Nader, Maria Stepanova, Zobair M Younossi, null null
Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt. Journal of viral hepatitis (2024)
Faisal M Sanai, Hassan O Odah, Kanan Alshammari, Adnan Alzanbagi, Murooj Alsubhi, Hani Tamim, Ashwaq Alolayan, Ahmed Alshehri, Saleh A Alqahthani
Nivolumab as Second-Line Therapy Improves Survival in Patients with Unresectable Hepatocellular Carcinoma. Cancers 16 (12) (2024)
Wesam Bahitham, Siraj Alghamdi, Ibrahim Omer, Ali Alsudais, Ilana Hakeem, Arwa Alghamdi, Reema Abualnaja, Faisal M Sanai, Alexandre Soares Rosado, Consolato Maria Sergi
Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Biomedicines 12 (3) (2024)
Saleh A Alqahtani, Yusuf Yilmaz, Mohamed El Kassas, Khalid Alswat, Faisal M Sanai, May AlZahrani, Faisal Abaalkhail, Manal AlShaikh, Waleed K Al-Hamoudi, Fatema Nader, Maria Stepanova, Zobair M Younossi, null null
Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt. Journal of viral hepatitis 31 (6) (2024)
Faisal M Sanai, Hassan O Odah, Kanan Alshammari, Adnan Alzanbagi, Murooj Alsubhi, Hani Tamim, Ashwaq Alolayan, Ahmed Alshehri, Saleh A Alqahthani
Nivolumab as Second-Line Therapy Improves Survival in Patients with Unresectable Hepatocellular Carcinoma. Cancers 16 (12) (2024)
Khalid I Bzeizi, Mohammad Arabi, Negar Jamshidi, Ali Albenmousa, Faisal M Sanai, Waleed Al-Hamoudi, Saad Alghamdi, Dieter Broering, Saleh A Alqahthani
Conventional Transarterial Chemoembolization Versus Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Cancers 13 (24) (2021)
Sarah Blach, Faisal M Sanai
HCV Burden and Barriers to Elimination in the Middle East. Clinical liver disease 14 (6) (2020)
Faisal M Sanai, Abdullah S Alghamdi, Ahmad A Afghani, Khalid Alswat, Adnan AlZanbagi, Mosfer N Alghamdi, Abdallah AlMousa, Mohammed Aseeri, Abdullah M Assiri, Mohamed A Babatin
High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1-infected patients with severe chronic kidney disease. Liver international : official journal of the International Association for the Study of the Liver 38 (8) (2018)
Ahmed Ali Al-Qahtani, M R Al-Anazi, N Nazir, K Wani, A A Abdo, Faisal M Sanai, M Q Khan, H I Al-Ashgar, A Albenmousa, W K Al-Hamoudi, K A Alswat, M N Al-Ahdal
Association of single nucleotide polymorphisms in microRNAs with susceptibility to hepatitis B virus infection and HBV-related liver complications: A study in a Saudi Arabian population. Journal of viral hepatitis 24 (12) (2017)